Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrahydrobiopterin-dependent enzymes are a group of enzymes that require tetrahydrobiopterin (BH4) as an essential cofactor for their catalytic activity. BH4 is present in nearly every cell or tissue of higher organisms and plays a central role in several critical metabolic pathways, particularly those involving amino acid metabolism and neurotransmitter synthesis. Key enzymes include phenylalanine hydroxylase (PAH), tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and nitric oxide synthases (NOSs). They are involved in synthesis of monoamine neurotransmitters, metabolism of phenylalanine, and production of nitric oxide. Deficiencies or dysfunctions can result in severe neurological disorders and are implicated in cardiovascular diseases.
Various; depends on specific enzyme. Includes enzyme inhibition, BH4 supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrahydrobiopterin-Dependent Enzymes (BH4-dependent enzymes).